Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

European shares start week on firm footing, vaccine developments eyed

Published 07/09/2020, 08:22
Updated 07/09/2020, 08:24
© Reuters.
DE40
-
CSL
-
AZN
-
STOXX
-
SX7P
-
SXAP
-
SXDP
-
SXIP
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
Sept 7 (Reuters) - European shares rebounded on Monday after
a Wall Street-led rout in technology stocks kept global
sentiment subdued in the previous week, with investors keeping a
close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a
potential COVID-19 vaccine in January after a deal was struck
with CSL CSL.AX to manufacture two vaccines - one developed by
rival AstraZeneca AZN.L and Oxford University, and another in
CSL's own labs with the University of Queensland. AstraZeneca rose 1.5%. The European healthcare sector index
.SXDP jumped 0.9%.
The STOXX 600 index .STOXX was 0.8% higher by 0709 GMT,
with Frankfurt shares .GDAXI leading gains after rising 1%.
Shares of insurers .SXIP , banks .SX7P and automakers
.SXAP climbed more than 1% in early trading.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.